Clinical Trials · NCT01616927
Study of Lanreotide to Treat Polycystic Kidney Disease
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- University Medical Center Groningen
- Enrollment
- 300
- Start date
- Jun 2012
- Locations
- 4 sites, Netherlands
- Primary endpoint
- Change in renal function